BBUSvsIBB
JPMorgan BetaBuilders U.S. Equity ETF against iShares Biotechnology ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| BBUS | IBB | |
|---|---|---|
| Expense ratio | 0.020% | 0.45% |
| Assets | $9.6B | $10.6B |
| Net flow, 1 month | +$298M | +$124M |
| Net flow, 1 year | +$2.6B | +$1.8B |
| Return, YTD | +14.2% | +20.3% |
| Return, 1 year | +15.7% | +34.9% |
| Avg daily volume | 274K | 1.6M |
| Holdings | 575 | 221 |
| Listed | Mar 11, 2019 | Feb 5, 2001 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS